Physician profile
Luis Chavez
NPI 1639576622
$5,543.37
in general payments reported to CMS, 2019-2025
15 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $423 · 2021: $189 · 2022: $651 · 2023: $861 · 2024: $1,234 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,749.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,197.28 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $1,194.05 | 2019-2025 | Tepezza, Evenity, Repatha |
| Lilly USA, LLC | $996.07 | 2019-2025 | Mounjaro, Zepbound, Humulin |
| Abbott Laboratories | $381.14 | 2019-2025 | Proclaim, Eterna, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.51 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $258.38 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $252.39 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Xeris Pharmaceuticals, INC. | $236.02 | 2025 | Recorlev, Gvoke Hypopen |
| Cequr Corporation | $219.35 | 2024-2025 | Cequr Simplicity |
| Medtronic, INC. | $165.32 | 2022-2024 | Minimed 780g |
| Horizon Therapeutics Plc | $123.94 | 2020 | |
| Baxter Healthcare | $103.27 | 2024 | Tisseel |
| Recordati_rare_diseases_inc. | $76.30 | 2023 | Isturisa |
| Pfizer INC. | $26.94 | 2023 | |
| Insulet Corporation | $18.41 | 2023 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.